GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
-23.35%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$232M
AUM Growth
+$232M
(-8%)
Cap. Flow
+$29.9M
Cap. Flow
% of AUM
12.86%
Top 10 Holdings %
Top 10 Hldgs %
63.9%
Holding
43
New
8
Increased
9
Reduced
6
Closed
7
Top Buys
| 1 |
RLYP
RELYPSA INC COM
RLYP
|
$9.79M |
| 2 |
Exelixis
EXEL
|
$8.92M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$8.44M |
| 4 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$8.36M |
| 5 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$8.08M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$15.4M |
| 2 |
Ascendis Pharma
ASND
|
$5.5M |
| 3 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$4.63M |
| 4 |
SGNT
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
|
$3.45M |
| 5 |
ATRS
Antares Pharma, Inc.
ATRS
|
$3.03M |
Sector Composition
| 1 | Healthcare | 58.75% |
| 2 | Technology | 8.1% |
